Multiple drugsCardiac toxicities following off-label treatment: 3 case reports

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2020年 / 1823卷 / 1期

关键词：

D O I：

10.1007/s40278-020-83873-2

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：245 / 245

相关论文

共 50 条

[1] BuprenorphineVarious toxicities following off-label treatment: 2 case reports
[J]. Reactions Weekly, 2020, 1832 (1) : 81 - 81
[2] DenosumabVarious toxicities following off-label treatment: 2 case reports
[J]. Reactions Weekly, 2019, 1781 (1) : 136 - 136
[3] RituximabVarious toxicities following an off-label use: 3 case reports
[J]. Reactions Weekly, 2018, 1683 (1) : 600 - 600
[4] PazopanibVarious toxicities following off-label use: 3 case reports
[J]. Reactions Weekly, 2023, 1939 (1) : 375 - 375
[5] DasatinibVarious toxicities following off-label use: 3 case reports
[J]. Reactions Weekly, 2021, 1881 (1) : 92 - 92
[6] BelantamabVarious toxicities following off-label use: 3 case reports
[J]. Reactions Weekly, 2023, 1961 (1) : 96 - 96
[7] TocilizumabVarious toxicities following off-label use: 3 case reports
[J]. Reactions Weekly, 2022, 1911 (1) : 386 - 386
[8] BlinatumomabVarious toxicities following off-label use: 3 case reports
[J]. Reactions Weekly, 2020, 1809 (1) : 74 - 74
[9] TetrabenazineVarious toxicities following off-label use: 3 case reports
[J]. Reactions Weekly, 2021, 1877 (1) : 375 - 375
[10] PyridostigmineVarious toxicities following off-label use: 3 case reports
[J]. Reactions Weekly, 2018, 1733 (1) : 281 - 281

← 1 2 3 4 5 →